兴齐眼药(300573.SZ)发布前三季度业绩，归母净利润5.99亿元，增长105.98%

Core Viewpoint - The company reported significant growth in both revenue and net profit for the first three quarters of 2025, indicating strong operational performance and financial health [1] Financial Performance - The company's revenue for the first three quarters reached 1.904 billion yuan, representing a year-on-year increase of 32.27% [1] - The net profit attributable to shareholders was 599 million yuan, showing a remarkable year-on-year growth of 105.98% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 596 million yuan, reflecting a year-on-year increase of 105.76% [1] - The basic earnings per share stood at 2.44 yuan [1]